Controlling Hyperglycemia Among Minority Population



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 64
Updated:1/28/2018
Start Date:January 2016
End Date:September 2017

Use our guide to learn which trials are right for you!

Controlling Hyperglycemia Among Minority Population (CHAMP): A Randomized Controlled Trial of Two Diabetes Interventions for Underserved Communities

The purpose of this study is to compare the efficacy of three approaches in diabetes
management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual
hospital-based care. The goal is to determine the most cost-effective method of diabetes
management among an economically-disadvantaged, minority population.

The CHAMP study will test the efficacy of two interventions designed to decrease uncontrolled
hyperglycemia (defined as Hemoglobin-A1C (A1C) at or above 9%) among adults with diabetes.
Patients from a safety-net hospital will be randomized into three groups: 1) a control group,
2) an intervention providing diabetes self-care text messages, or 3) an intervention using
community health workers to provide diabetes education and linkage to care. Secondary
objectives include increasing diabetes knowledge, improving diabetes self-management, and
increasing use of primary care (i.e., make one visit to the physician in 6 months) among the
intervention participants. A cost-effectiveness analysis will determine the most appropriate
way to reduce the burden of uncontrolled diabetes.

Inclusion Criteria:

*Hyperglycemia with A1C ≥9%

Exclusion Criteria:

- Lives greater than 20 miles driving distance from Mount Sinai Hospital

- Pregnant women with gestational diabetes

- Advanced end-organ complications due to diabetes that include: end-stage renal
disease, stroke with paresis, Congestive Heart Failure (NYHA class III or IV), or
other major end-organ complication of diabetes

- Receiving treatment for a major psychiatric disorder (i.e. schizophrenia)

- Unable to understand and give informed consent in either English or Spanish

- Currently or previously participated in a diabetes research study

- Family member currently enrolled in a diabetes research study

- Previously received diabetes care related cell phone text messages

- Unable to receive text messages 3-4 times per week

- Living in a homeless shelter or temporary housing

- Plans to travel outside of the United States for more than 3 months in next year
We found this trial at
1
site
Chicago, Illinois 60608
Phone: 773-257-6062
?
mi
from
Chicago, IL
Click here to add this to my saved trials